Literature DB >> 10348985

Humoral immune response kinetics in Philander opossum and Didelphis marsupialis infected and immunized by Trypanosoma cruzi employing an immunofluorescence antibody test.

A P Legey1, A P Pinho, S C Chagas Xavier, L L Leon, A M Jansen.   

Abstract

Philander opossum and Didelphis marsupialis considered the most ancient mammals and an evolutionary success, maintain parasitism by Trypanosoma cruzi without developing any apparent disease or important tissue lesion. In order to elucidate this well-balanced interaction, we decided to compare the humoral immune response kinetics of the two didelphids naturally and experimentally infected with T. cruzi and immunized by different schedules of parasite antigens, employing an indirect fluorescence antibody test (IFAT). Both didelphids responded with high serological titers to different immunization routes, while the earliest response occurred with the intradermic route. Serological titers of naturally infected P. opossum showed a significant individual variation, while those of D. marsupialis remained stable during the entire follow-up period. The serological titers of the experimentally infected animals varied according to the inoculated strain. Our data suggest that (1) IFAT was sensitive for follow-up of P. opossum in natural and experimental T. cruzi infections; (2) both P. opossum and D. marsupialis are able to mount an efficient humoral immune response as compared to placental mammals; (3) experimentally infected P. opossum and D. marsupialis present distinct patterns of infection, depending on the subpopulation of T. cruzi, (4) the differences observed in the humoral immune responses between P. opossum and D. marsupialis, probably, reflect distinct strategies selected by these animals during their coevolution with T. cruzi.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10348985     DOI: 10.1590/s0074-02761999000300016

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  6 in total

1.  Infectivity for mice of Trypanosoma cruzi I and II strains isolated from different hosts.

Authors:  Marta Bértoli; Miriam Hitomi Andó; Max Jean De Ornelas Toledo; Silvana Marques De Araújo; Mônica Lúcia Gomes
Journal:  Parasitol Res       Date:  2006-01-31       Impact factor: 2.289

Review 2.  Trypanosoma cruzi and Chagas' Disease in the United States.

Authors:  Caryn Bern; Sonia Kjos; Michael J Yabsley; Susan P Montgomery
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

3.  Molecular cloning and characterization of the polymorphic MHC class II DBB from the tammar wallaby (Macropus eugenii).

Authors:  Teena L Browning; Katherine Belov; Robert D Miller; Mark D B Eldridge
Journal:  Immunogenetics       Date:  2004-01-30       Impact factor: 2.846

4.  Over-dispersed Trypanosoma cruzi parasite load in sylvatic and domestic mammals and humans from northeastern Argentina.

Authors:  Gustavo Fabián Enriquez; Jacqueline Bua; María Marcela Orozco; Natalia Paula Macchiaverna; Julián Antonio Alvarado Otegui; Hernán Darío Argibay; María Del Pilar Fernández; Ricardo Esteban Gürtler; Marta Victoria Cardinal
Journal:  Parasit Vectors       Date:  2022-01-24       Impact factor: 3.876

5.  Follow up of natural infection with Trypanosoma cruzi in two mammals species, Nasua narica and Procyon lotor (Carnivora: Procyonidae): evidence of infection control?

Authors:  Fernando Martínez-Hernández; Emilio Rendon-Franco; Lilia María Gama-Campillo; Claudia Villanueva-García; Mirza Romero-Valdovinos; Pablo Maravilla; Ricardo Alejandre-Aguilar; Nancy Rivas; Alex Córdoba-Aguilar; Claudia Irais Muñoz-García; Guiehdani Villalobos
Journal:  Parasit Vectors       Date:  2014-08-29       Impact factor: 3.876

Review 6.  Landmarks of the Knowledge and Trypanosoma cruzi Biology in the Wild Environment.

Authors:  Ana Maria Jansen; Samanta Cristina das Chagas Xavier; André Luiz R Roque
Journal:  Front Cell Infect Microbiol       Date:  2020-02-06       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.